SLC2A3 and neoplasm: GLUT3 is also overexpressed in several cancers, and its upregulation correlates with poor survival and tumor aggressiveness in brain32,33, lung34,35, laryngeal36, breast37, gastric38, liver39, and colorectal40 cancers.